Sight Sciences (SGHT) Operating Leases (2023 - 2026)
Sight Sciences' quarterly Operating Leases came in at $870000.0 in Q1 2026, up 165.24% year-on-year from $328000.0 in Q1 2025, and up 1751.06% quarter-over-quarter from $47000.0 in Q3 2025.
Sight Sciences has reported Operating Leases for 4 years, with the latest figure at $870000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 165.24% year-over-year to $870000.0; the trailing twelve-month figure through Mar 2026 stood at $870000.0 (up 165.24% YoY), and the FY2024 full-year result was $473000.0, down 48.25% from the prior year.
- Operating Leases for Q1 2026 stood at $870000.0, up from $47000.0 in the prior quarter.
- The five-year high for Operating Leases was $914000.0 in Q4 2023, with the low at $47000.0 in Q3 2025.
- Average Operating Leases over 4 years is $522000.0, with a median of $543500.0 recorded in 2024.
- Year-over-year, Operating Leases slumped 92.35% in 2025 and soared 165.24% in 2026.
- Tracing SGHT's Operating Leases over 4 years: stood at $914000.0 in 2023, then tumbled by 48.25% to $473000.0 in 2024, then slumped by 90.06% to $47000.0 in 2025, then jumped by 1751.06% to $870000.0 in 2026.
- The last three Operating Leases figures came in at $870000.0 (Q1 2026), $47000.0 (Q3 2025), and $183000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sight Sciences | 247.60 Mn | 162.64 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 870,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 328,000.00 |
| Dec 31, 2024 | 473,000.00 |
| Sep 30, 2024 | 614,000.00 |
| Jun 30, 2024 | 747,000.00 |
| Dec 31, 2023 | 914,000.00 |